Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Net Cash Flow (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Net Cash Flow came in at -$1.3 billion in Q2 2026, up 93.66% year-over-year from -$656.3 million in Q2 2025, and down 163.42% quarter-over-quarter from $2.0 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Net Cash Flow (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Net Cash Flow across 18 years of filings, most recently posting -$1.3 billion for Q2 2026.

  • In Q2 2026, Net Cash Flow rose 93.66% year-over-year to -$1.3 billion; the TTM figure through Jun 2026 stood at $1.9 billion (up 129.29% YoY), while the FY2025 annual figure was -$4.6 billion, down 281.34% from the prior year.
  • Net Cash Flow came in at -$1.3 billion for Q2 2026 at Johnson & Johnson, down from $2.0 billion in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $14.3 billion in Q1 2025 to a low of -$20.1 billion in Q2 2025.
  • Average Net Cash Flow over 5 years is -$82.3 million, with a median of -$405.0 million recorded in 2024.
  • Year-over-year, Net Cash Flow jumped 414.6% in 2023 and plunged 3831.57% in 2025.
  • Over 5 years, Net Cash Flow stood at -$4.0 billion in 2022, then soared by 149.65% to $2.0 billion in 2023, then jumped by 115.5% to $4.3 billion in 2024, then plunged by 66.34% to $1.5 billion in 2025, then tumbled by 187.35% to -$1.3 billion in 2026.
  • Per Business Quant data, the three most recent Net Cash Flow figures were -$1.3 billion in Q2 2026, $2.0 billion in Q1 2026, and $1.5 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -1.27 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -2.82 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 757.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -722.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -851.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 918.27 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 374.50 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 407.41 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 521.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 -1.27 Bn
Mar 29, 2026 2.00 Bn
Dec 28, 2025 1.46 Bn
Sep 28, 2025 -300.00 Mn
Jun 29, 2025 -20.05 Bn
Mar 30, 2025 14.30 Bn
Dec 29, 2024 4.32 Bn
Sep 29, 2024 -5.02 Bn
Jun 30, 2024 -510.00 Mn
Mar 31, 2024 3.74 Bn
Dec 31, 2023 2.01 Bn
Oct 1, 2023 -1.29 Bn
Jul 2, 2023 -5.59 Bn
Apr 2, 2023 12.71 Bn
Jan 1, 2023 -3.79 Bn
Apr 3, 2022 -4.04 Bn
Oct 3, 2021 3.36 Bn
Jul 4, 2021 1.62 Bn
Apr 4, 2021 -1.24 Bn
Jan 3, 2021 -5.20 Bn